2K
Articles
52.6K
Citations
3.5
avg. Impact Factor
100
h-index

Most Cited Articles of Department of Oncology in 2017

TitleJournalYearCitations
Dabrafenib plus trametinib in patients with previously untreated BRAF-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trialLancet Oncology, The2017461
Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTsCancer Treatment Reviews2017272
International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman diseaseBlood2017234
Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijackingNature Genetics2017220
mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapyBlood2017206
A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancerJournal of Cachexia, Sarcopenia and Muscle2017151
Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studiesMolecular Cancer2017142
The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLCJournal of Thoracic Oncology2017132
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker studyAnnals of Oncology2017116
Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical TrialJAMA Oncology201792
CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical modelsScientific Reports201788
Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiativeUnited European Gastroenterology Journal201780
Geriatric assessment is superior to oncologists' clinical judgement in identifying frailtyBritish Journal of Cancer201778
Muscle mass and association to quality of life in non-small cell lung cancer patientsJournal of Cachexia, Sarcopenia and Muscle201776
Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate CancerCell Reports201772
DNA methylation at enhancers identifies distinct breast cancer lineagesNature Communications201771
c-Myc Antagonises the Transcriptional Activity of the Androgen Receptor in Prostate Cancer Affecting Key Gene NetworksEBioMedicine201763
Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) - study protocol for a national multicentre randomized controlled trialBMC Surgery201761
Multilevel genomics of colorectal cancers with microsatellite instability-clinical impact of JAK1 mutations and consensus molecular subtype 1Genome Medicine201753
The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancerPLoS ONE201753
Genetic modifiers of CHEK2*1100delC-associated breast cancer riskGenetics in Medicine201751
Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancerCancer Immunology, Immunotherapy201749
Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-upBreast Cancer Research201748
Variants in and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated OtotoxicityClinical Cancer Research201747
Profiling of microRNAs in tumor interstitial fluid of breast tumors - a novel resource to identify biomarkers for prognostic classification and detection of cancerMolecular Oncology201741